SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ocwen Financial Corporation of Class Action Lawsuit and Upcoming Deadline -- OCN

NEW YORK, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Ocwen Financial Corporation ("Ocwen" or the "Company") (NYSE: OCN ) and certain of its officers. The class action, filed in United States District Court, Southern District of Florida, West Palm Division, and docketed under 14-cv-81064, is on behalf of a class consisting of all persons or entities who purchased Ocwen securities between May 2, 2013 and August 11, 2014, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").

If you are a shareholder who purchased Ocwen securities during the Class Period, you have until October 14, 2014 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Ocwen is a financial services holding company which, through its subsidiaries, is engaged in the servicing and origination of forward and reverse mortgage loans in the United States and internationally.

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose material information regarding the Company's improper business and operational practices including, among other things, that Ocwen's mortgage servicing practices violated applicable regulations and laws; that the Company's executives allowed related company Altisource Portfolio Solutions, S.A. ("Altisource")—a company of which Defendant William C. Erbey, Ocwen's Chairman of the Board, owns approximately 27% of its shares outstanding-to impose wholly unreasonable rates for services provided to Ocwen; and that Defendant William C. Erbey, along with other directors and officers, were directly involved in approving Ocwen's conflicted transactions with Altisource. In addition, the Company's financial results were artificially inflated during the Class Period.

On December 19, 2013, the first of several partial disclosures regarding the Company's illicit practices in connection with its mortgage servicing business was published. A New York Times article titled "Big Subprime Mortgage Loan Servicer Agrees to $2.2 billion Settlement" announced a $2.2 billion settlement entered into by Ocwen with the Consumer Financial Protection Bureau in connection with the Company's mortgage servicing business. The article stated that the Bureau "believe[s] that Ocwen violated federal consumer financial laws at every stage of the mortgage servicing process[.]"

On February 26, 2014, an article by Bloomberg titled, "Lawsky Cites Ocwen Conflicts as He Reviews Wells Fargo Deal," continued to expose Ocwen's deficient operational practices. The article disclosed that the New York Department of Financial Services ("NY Department of Financial Services") issued a letter to the Company expressing concerns regarding Ocwen's business transactions with related companies and Defendant Erbey's and other officers' and directors' involvement in approving transactions with said affiliates.

On August 4, 2014, the NY Department of Financial Services issued a second letter to Ocwen stating that it was reviewing what it called "a troubling transaction" with Altisource relating to the provision of force-placed insurance which is "designed to funnel as much as $65 million in fees annually from already-distressed homeowners to Altisource for minimal work." The article went on to question the "the role that Ocwen's Executive Chairman William C. Erbey played in approving this arrangement" which "appears to be inconsistent with public statements Ocwen has made, as well as representations in company SEC filings."

The full truth finally emerged on August 12, 2014, when the Company disclosed yet more problems with its business and operations when it announced that certain transactions with another related company in which Defendant Erbey holds a substantial stake-Home Loan Servicing Solutions, Ltd. ("HLSS")—would lead to the Company restating its financial results for the fiscal year ended December 31, 2013 and the quarter ended March 31, 2014. As a result of the restatement, the Company announced that it expects to report material weaknesses in its internal controls. As a result of this disclosure, Ocwen's stock price declined an additional $1.18 per share, or 4.48%, on higher than average trading volume.

Overall, in response to these disclosures, the Company's stock price plummeted an aggregate 55%, from a closing of $56.00 on December 18, 2013 to a closing price of $25.16 on August 12, 2014.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

Robert S. Willoughby Pomerantz LLP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Huggies and Walgreens Uniting to Tackle Diaper Need

Updated Category News Views 300

Partnering to Tackle Diaper Needs Huggies and Walgreens are thrilled to kick off a meaningful initiative designed to support families dealing with diaper need. For each pack of Huggies Diapers bought at Walgreens, either in stores or online, Huggies will donate a day's worth of diapers to the National Diaper Bank Network, aiming to contribute as many as one million...

Continue Reading
Surging Growth of Fatty Methyl Ester Sulfonate Market By 2033

Updated Category News Views 144

Exploring the Future of the Fatty Methyl Ester Sulfonate Market The dynamic world of the fatty methyl ester sulfonate (FMES) market is entering an exciting phase of growth. Beginning at an estimated value of US$ 805.9 million in 2024, the forecast projects the market to surge to US$ 2,095.1 million by 2033. This impressive leap represents an annual growth rate of 11.20%,...

Continue Reading
Biden Administration Approves Perpetua's Mining Project

Updated Category News Views 151

Biden Administration Approves Perpetua's Mining Project In a significant move for resource management and economic development, the Biden administration has granted the final mining permit for Perpetua Resources' antimony and gold mine located in Idaho. This decision comes in response to concerns regarding China's substantial control over the global market for antimony, a...

Continue Reading
Neurocrine Biosciences Set to Share Q2 2025 Financial Insights

Updated Category News Views 130

Neurocrine Biosciences Announces Upcoming Financial Conference Call Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a leader in the field of neuroscience, is excited to inform stakeholders about its scheduled conference call and webcast. The event is set for the afternoon of July 30, where financial results for the second quarter of 2025 will be shared. This moment allows...

Continue Reading
Societe Generale Updates on Universal Registration Document

Updated Category News Views 127

Introducing the Second Amendment Societe Generale has exciting news regarding the second amendment to its 2025 Universal Registration Document. This essential document plays a crucial role in ensuring transparency and compliance with regulatory frameworks. The amendment was officially filed with the French Financial Markets Authority (AMF), ensuring that all stakeholders...

Continue Reading